The FDA announced on 2012-08-28 that Hospira Inc. is recalling Diazepam Injection Vials due to a lack of sterility assurance caused by loose crimps on fliptop vials, according to the FDA.
How to tell if you have it
- Brand: Hospira
- Product: Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial
- NDC: 0409-3213-12
- Lot codes: 17-100-EV and 17-399-EV
- Units affected: 172,350 vials
The hazard
The recall addresses a lack of assurance of sterility resulting from loose crimps applied to the fliptop vial, according to the FDA.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include a 2017-04-21 recall for hair particulates in syringes and a 2016-11-01 recall for broken ampule tips risking infection.